Sorafenib and Erlotinib in Treating Patients With Metastatic or Unresectable Solid Tumors
Conditions
- Unspecified Adult Solid Tumor, Protocol Specific
Interventions
- DRUG: erlotinib hydrochloride
- DRUG: sorafenib tosylate
Sponsor
University Health Network, Toronto
Collaborators